The gold standard for diagnosing CPP is laboratory confirmation of hypothalamic‒pituitary‒gonadal (HPG) axis activation via stimulation testing with either GnRH or the synthetic GnRH analogue leuprolide, with a peak stimulated LH concentration greater than 5 U/L [6]. This evidence concerns the gene GNRH1 and central precocious puberty.